Buscar resultados de ensayos clínicos
Ebola Virus Disease - 26 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Efficacy of Favipiravir Against Severe Ebola Virus Disease Condición: Ebola Virus Disease Fecha: 2016-01-19 Intervenciones:
|
Recruiting |
Nombre del estudio: PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response Condición: Ebola Virus Disease Fecha: 2017-03-30 |
Recruiting |
Nombre del estudio: Multiple Treatments for Ebola Virus Disease (EVD) Condición: Ebola Virus Disease Fecha: 2015-03-01 Intervenciones:
|
Recruiting |
Nombre del estudio: Partnership for Research on Ebola VACcinations Condición: Ebola Virus Disease Fecha: 2016-08-16 Intervenciones:
|
Enrolling by invitation |
Nombre del estudio: A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease Condición: Acute Ebola Virus Disease Fecha: 2014-11-04 Intervenciones: Biological: INTERCEPT Plasma Plasma will be collected from eligible volunteer donors who have recovered |
Completed |
Nombre del estudio: Efficacy of Favipiravir Against Ebola (JIKI) Condición: Ebola Virus Disease Fecha: 2014-12-16 Intervenciones: Drug: Favipiravir Group A1: Day-0 (inclusion), h0: 2400 mg |
Recruiting |
Nombre del estudio: Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up Condición: Ebola Virus Disease Fecha: 2015-04-30 |
Completed |
Nombre del estudio: A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults. Condición: Ebola Virus Disease Fecha: 2014-12-22 Intervenciones:
|
Enrolling by invitation |
Nombre del estudio: Persistence of the Immune Response After Ebola Vaccine Immunisation Condición: Ebola Virus Disease Fecha: 2017-05-02 |
Enrolling by invitation |
Nombre del estudio: Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment Condición: Ebola Virus Disease Fecha: 2015-01-05 Intervenciones: Procedure: Convalescent Plasma Treatment This pilot trial will treat subjects in the ECP Group with ECP |